The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry | Zendy

David Petroff | Zendy; Anke Tönjes | Zendy; M Grußendorf | Zendy; Michael Droste | Zendy; Christina Dimopoulou | Zendy; Günter K. Stalla | Zendy; Cornelia Jaursch-Hancke | Zendy; Manuel Mai | Zendy; Jochen Schopohl | Zendy; Christof Schöfl | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry

Author(s) -

David Petroff,

Anke Tönjes,

M Grußendorf,

Michael Droste,

Christina Dimopoulou,

Günter K. Stalla,

Cornelia Jaursch-Hancke,

Manuel Mai,

Jochen Schopohl,

Christof Schöfl

Publication year - 2015

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2015-2372

Subject(s) - acromegaly , medicine , incidence (geometry) , population , cancer registry , cancer , thyroid cancer , colorectal cancer , gastroenterology , oncology , hormone , growth hormone , physics , environmental health , optics

Acromegaly is a rare disease characterized by high serum levels of GH and IGF-1. Animal studies have demonstrated links between these hormones and cancer, but data regarding cancer incidence among acromegaly patients are inconsistent. Moreover, therapy options have changed considerably since many of the aforementioned data were collected.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research